Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
Core EBITDA Growth

    Back to All Ratios
ANUH PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

ANUH PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -19.2051.689.98-5.38102.79

What is the latest Core EBITDA Growth ratio of ANUH PHARMA ?

The latest Core EBITDA Growth ratio of ANUH PHARMA is -19.20 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-19.20
Mar202451.68
Mar20239.98
Mar2022-5.38
Mar2021102.79

How is Core EBITDA Growth of ANUH PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 -19.2
Negative
Mar2024 51.68
417.84
Mar2023 9.98
Positive
Mar2022 -5.38
Negative
Mar2021 102.79 -

Other Financial Ratios of ANUH PHARMA


Compare Core EBITDA Growth ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹762.6 Cr 0.2% 4.1% -7.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

0.2%

4.1%

-7.4%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses